Register to chat with like-minded investors on our interactive forums.

Get Started

AGEN

Agenus (AGEN)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AGEN

<< Previous 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Next >>

Date	Time	Source	Headline	Symbol	Company
05/07/2020	8:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGEN	Agenus Inc
05/07/2020	8:00AM	PR Newswire (US)	Agenus First Quarter Results and Update	NASDAQ:AGEN	Agenus Inc
04/28/2020	4:03PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AGEN	Agenus Inc
04/28/2020	11:50AM	PR Newswire (US)	Agenus to Report First Quarter 2020 Financial Results on May 7, 2020 and Host Conference Call and Webcast	NASDAQ:AGEN	Agenus Inc
04/24/2020	5:25PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
04/10/2020	2:05PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
04/07/2020	1:04PM	PR Newswire (US)	Agenus Receives Fast Track Designation for Balstilimab in Advanced Cervical Cancer	NASDAQ:AGEN	Agenus Inc
04/03/2020	2:52PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
04/03/2020	2:33PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
04/03/2020	2:18PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
03/30/2020	9:01AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGEN	Agenus Inc
03/20/2020	4:01PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:AGEN	Agenus Inc
03/16/2020	5:32PM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:AGEN	Agenus Inc
03/12/2020	8:04AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGEN	Agenus Inc
03/12/2020	7:45AM	PR Newswire (US)	Agenus Receives Fast Track Designation for Balstilimab & Zalifrelimab in Advanced Cervical Cancer	NASDAQ:AGEN	Agenus Inc
03/12/2020	7:30AM	PR Newswire (US)	Agenus Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update	NASDAQ:AGEN	Agenus Inc
03/10/2020	9:14AM	PR Newswire (US)	First QS-21 Royalty Payment Due to Agenus is Triggered	NASDAQ:AGEN	Agenus Inc
03/03/2020	8:00AM	PR Newswire (US)	Agenus to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020 with Conference Call and Webcast	NASDAQ:AGEN	Agenus Inc
02/24/2020	4:42PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGEN	Agenus Inc
02/20/2020	9:56AM	PR Newswire (US)	Agenus Announces Positive Interim Data from Balstilimab and Zalifrelimab Clinical Trials in Second-Line Cervical Cancer	NASDAQ:AGEN	Agenus Inc
02/14/2020	1:45PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AGEN	Agenus Inc
02/06/2020	3:12PM	PR Newswire (US)	Agenus Announces Investor Day on February 20, 2020	NASDAQ:AGEN	Agenus Inc
02/05/2020	11:32AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AGEN	Agenus Inc
01/09/2020	10:59AM	PR Newswire (US)	Agenus Announces the Appointment of Dr. Jennifer Buell to the position of President and COO	NASDAQ:AGEN	Agenus Inc
01/08/2020	8:30AM	PR Newswire (US)	Agenus Commences Phase 1 trial with AGEN1223	NASDAQ:AGEN	Agenus Inc
12/19/2019	7:30AM	PR Newswire (US)	Agenus Commences Combination Trial of its Next-Gen CTLA-4 with its PD-1 Antibody	NASDAQ:AGEN	Agenus Inc
11/12/2019	12:48PM	PR Newswire (US)	Agenus to Host R&D Day November 15, 2019	NASDAQ:AGEN	Agenus Inc
11/11/2019	8:00AM	PR Newswire (US)	Agenus receives $10M from UroGen Pharma for rights to Zalifrelimab (CTLA-4) for intravesical treatment of urinary tract cance...	NASDAQ:AGEN	Agenus Inc
11/07/2019	4:10PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AGEN	Agenus Inc
11/07/2019	2:56PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc

Showing the most relevant articles for your search:NASDAQ:AGEN

<< Previous 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Next >>

Ethema Health (PK)

Asia Broadband (PK)

Fannie Mae (QB)

Northwest Biotherapeutics (QB)

Digital Brand Media and ... (PK)

Anavex Life Sciences

Brookmount Explorations (PK)

RespireRx Pharmaceuticals (PK)

Virexit Technologies (PK)

Lightwave Logic

Rennova Health (PK)

SMC Entertainment (PK)

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock